5-Year Clinical Results of a Randomized Trial Evaluating the Absorb Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in De Novo Native Coronary Artery Lesions: Data From the ABSORB Japan Trial

被引：1
|
作者：
Kozuma, Ken [1 ]
Kimura, Takeshi [2 ]
Tanabe, Kengo [3 ]
机构：
[1] Teikyo Univ Hosp, Tokyo, Japan
[2] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[3] Mitsui Mem Hosp, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 74卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2019.08.220
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-165
引用
收藏
页码：B164 / B164
页数：1
相关论文
共 50 条
  • [21] A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
    Kimura, Takeshi
    Kozuma, Ken
    Tanabe, Kengo
    Nakamura, Sunao
    Yamane, Masahisa
    Muramatsu, Toshiya
    Saito, Shigeru
    Yajima, Junji
    Hagiwara, Nobuhisa
    Mitsudo, Kazuaki
    Popma, Jeffrey J.
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Ying, Shihwa
    Cao, Sherry
    Staehr, Peter
    Cheong, Wai-Fung
    Kusano, Hajime
    Stone, Gregg W.
    EUROPEAN HEART JOURNAL, 2015, 36 (47) : 3332 - 3342
  • [22] One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
    Yuldashev, Nabijon P.
    Gil, Robert J.
    Kurbanov, Rayshanbek D.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2018, 8 (01) : 20 - 25
  • [23] 5-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial
    Gao, Run-Lin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B47 - B47
  • [24] Comment on "Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial''
    Carvalho, Henrique Cyrne
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2017, 36 (01) : 73 - 75
  • [25] Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy
    Tijssen, Ruben Y. G.
    van der Schaaf, Rene J.
    Kraak, Robin P.
    Vink, Maarten A.
    Hofma, Sjoerd H.
    Arkenbout, E. Karin
    Weevers, Auke P. J. D.
    Kerkmeijer, Laura S. M.
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Beijk, Marcel A. M.
    Koch, Karel T.
    Baan, Jan, Jr.
    Vis, M. Marije
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 (01) : 89 - 96
  • [26] Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial
    Tanabe, Kengo
    Popma, Jeffrey J.
    Kozuma, Ken
    Saito, Shigeru
    Muramatsu, Toshiya
    Nakamura, Sunao
    Namiki, Atsuo
    Morino, Yoshihiro
    Hagiwara, Nobuhisa
    Uematsu, Masaaki
    Kawasaki, Tomohiro
    Fujii, Kenshi
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Ying, Shihwa
    Kusano, Hajime
    Stone, Gregg W.
    Kimura, Takeshi
    EUROINTERVENTION, 2018, 14 (09) : E1020 - E1028
  • [27] ABSORB trial: twelve months results of clinical evaluation of the Bioabsorbable Everolimus-Eluting coronary Stent system in the treatment of patients with de novo native coronary artery lesions
    Ormision, John
    Serruys, Patrick W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 36L - 37L
  • [28] Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Onuma, Yosinobu
    Serruys, Patrick W.
    Ormiston, John A.
    Regar, Evelyn
    Webster, Mark
    Thuesen, Leif
    Dudek, Dariusz
    Veldhof, Susan
    Rapoza, Richard
    EUROINTERVENTION, 2010, 6 (04) : 447 - 453
  • [29] Treatment of in-stent-restenosis with everolimus-eluting bioresorbable scaffolds - The 5-year results of the randomized ABSORB-ISR trial
    Bossard, Matthias
    Madanchi, Mehdi
    Attinger-Toller, Adrian
    Cioffi, Giacomo Maria
    Seiler, Thomas
    Majcen, Irena
    Zhi, Yuan
    Gjergjizi, Varis
    Toggweiler, Stefan
    Cuculi, Florim
    SWISS MEDICAL WEEKLY, 2023, 153 : 124S - 125S
  • [30] Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.
    Tijssen, Ruben Y. G.
    van der Schaaf, Rene J.
    Kraak, Robin P.
    Vink, Maarten A.
    Hofma, Sjoerd H.
    Arkenbout, Karin
    Weevers, Auke P. J. D.
    Kerkmeijer, Laura S. M.
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Beijk, Marcel A. M.
    Koch, Karel T.
    Baan, Jan, Jr.
    Vis, M. Marije
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (04) : S39 - S39
12345